Australia (AU)

Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (2021) Mihaela F, Zoran G, Kiril T, Jeffrey S, Ming Z, Reza A, Williamson SR, et al. Journal article The contribution of insects to global forest deadwood decomposition (2021) Seibold S, Rammer W, Hothorn T, Seidl R, Ulyshen MD, Lorz J, Cadotte MW, et al. Journal article Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN): PRRT in the Treatment of Neuroendocrine Tumor (NET) Patients (2021) Dureja S, Kolarova T, Mcdonnell M, Van Genechten D, Bouvier C, Gellerman E, O'Toole D, et al. Conference contribution Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline (2021) Tomson CR, Cheung AK, Mann JF, Chang TI, Cushman WC, Furth SL, Hou FF, et al. Journal article NuSTAR reveals the hidden nature of SS433 (2021) Middleton MJ, Walton DJ, Alston W, Dauser T, Eikenberry S, Jiang YF, Fabian AC, et al. Journal article Early development and coloniality in Oligophylloides from the Devonian of Morocco- Are Heterocorallia Palaeozoic octocorals? (2021) Berkowski B, Zapalski MK, Jarochowska E, Alderslade P Journal article Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity (2021) Wang J, Farkas C, Benyoucef A, Carmichael C, Haigh K, Wong N, Huylebroeck D, et al. Journal article Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis (2021) Meagher N, Koebel M, Anderson L, Tan A, Bolithon A, Anglesio M, Cohen P, et al. Conference contribution Secukinumab Efficacy in Psoriatic Arthritis: Machine Learning and Meta-analysis of Four Phase 3 Trials (2021) Gottlieb AB, Mease PJ, Kirkham B, Nash P, Balsa AC, Combe B, Rech J, et al. Journal article KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution